PP04   Presentation Time: 3:57 PM

Recent progresses in high-dose-rate (HDR) cervical cancer brachytherapy showed that complex interstitial (IS) and intracavity applicators, such as the Venezia applicator (Elekta, Veenendaal, The Netherlands), can improve the HR-CTV coverage while adequately protecting organs at risk (OARs). Although the Venezia applicator offers more degrees of freedom for catheter selection, efficient catheter and dose optimization algorithms are still lacking; it is difficult for practitioners to determine the optimal catheter configuration to achieve Pareto-optimal treatment plans.
Source: Brachytherapy - Category: Cancer & Oncology Authors: Source Type: research